PvCS/Montanide ISA-51 malaria vaccine

PvCS vaccine with Montanide ISA-51 adjuvant · Malaria Vaccine and Drug Development Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PvCS/Montanide ISA-51 malaria vaccine, covering 2026-01-28 to 2026-01-28. Get the full timeline:

Most recent: Clinical Trial Update: Phase IIa/b Trial of PvCS/Montanide ISA-51 Malaria Vaccine in Adults in Chocó, Colombia [Phase 2]